The pharma company Teitur Trophics that targets neurodegenerative diseases has joined the BII Creation House program. Neurodegenerative diseases are one of the greatest unmet clinical needs today. In the past years, none of the many hypotheses aiming at altering very specific pathways in the cells have been proven successful. As part of the Creation House … Continue reading BII funds therapeutics start-up from Aarhus University